Orion Porfolio Solutions LLC Has $1.98 Million Stock Holdings in Molina Healthcare, Inc $MOH

Orion Porfolio Solutions LLC increased its position in Molina Healthcare, Inc (NYSE:MOH) by 225.8% during the second quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 6,630 shares of the company’s stock after purchasing an additional 4,595 shares during the quarter. Orion Porfolio Solutions LLC’s holdings in Molina Healthcare were worth $1,975,000 as of its most recent SEC filing.

Several other hedge funds have also bought and sold shares of the company. Norges Bank bought a new stake in Molina Healthcare in the second quarter valued at approximately $212,113,000. Invesco Ltd. increased its holdings in shares of Molina Healthcare by 25.9% during the 2nd quarter. Invesco Ltd. now owns 1,601,574 shares of the company’s stock worth $477,109,000 after acquiring an additional 329,759 shares during the last quarter. Viking Global Investors LP bought a new stake in Molina Healthcare in the 2nd quarter valued at $79,665,000. AQR Capital Management LLC raised its stake in Molina Healthcare by 42.7% in the 1st quarter. AQR Capital Management LLC now owns 884,958 shares of the company’s stock valued at $288,125,000 after acquiring an additional 264,664 shares during the period. Finally, Marshall Wace LLP lifted its holdings in Molina Healthcare by 2,768.3% during the 2nd quarter. Marshall Wace LLP now owns 248,740 shares of the company’s stock valued at $74,100,000 after purchasing an additional 240,068 shares during the last quarter. 98.50% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Molina Healthcare

In other news, Director Richard M. Schapiro sold 357 shares of the stock in a transaction on Monday, November 24th. The stock was sold at an average price of $143.02, for a total transaction of $51,058.14. Following the sale, the director directly owned 11,352 shares of the company’s stock, valued at approximately $1,623,563.04. This represents a 3.05% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders own 1.10% of the company’s stock.

Molina Healthcare Stock Performance

Shares of NYSE:MOH opened at $163.74 on Friday. Molina Healthcare, Inc has a 12-month low of $133.40 and a 12-month high of $359.97. The company’s 50 day moving average price is $158.21 and its two-hundred day moving average price is $190.85. The firm has a market cap of $8.87 billion, a PE ratio of 10.14 and a beta of 0.52. The company has a quick ratio of 1.68, a current ratio of 1.68 and a debt-to-equity ratio of 0.92.

Molina Healthcare (NYSE:MOH) last issued its quarterly earnings results on Wednesday, October 22nd. The company reported $1.84 earnings per share (EPS) for the quarter, missing the consensus estimate of $3.97 by ($2.13). The company had revenue of $11.48 billion during the quarter, compared to the consensus estimate of $10.99 billion. Molina Healthcare had a net margin of 1.98% and a return on equity of 22.95%. The company’s quarterly revenue was up 11.0% on a year-over-year basis. During the same quarter last year, the firm posted $6.01 earnings per share. Molina Healthcare has set its FY 2025 guidance at 14.000-14.000 EPS. Equities research analysts predict that Molina Healthcare, Inc will post 24.4 earnings per share for the current year.

Analysts Set New Price Targets

Several equities analysts have recently weighed in on the stock. Deutsche Bank Aktiengesellschaft set a $165.00 price objective on shares of Molina Healthcare in a research report on Friday, October 24th. Morgan Stanley set a $158.00 price target on shares of Molina Healthcare in a research note on Friday, October 24th. UBS Group cut their price objective on shares of Molina Healthcare from $180.00 to $170.00 and set a “neutral” rating for the company in a research report on Friday, October 24th. Wall Street Zen downgraded Molina Healthcare from a “hold” rating to a “sell” rating in a research report on Saturday, October 25th. Finally, The Goldman Sachs Group lowered their target price on Molina Healthcare from $207.00 to $167.00 and set a “neutral” rating on the stock in a research note on Friday, October 24th. Three equities research analysts have rated the stock with a Buy rating, eleven have given a Hold rating and two have given a Sell rating to the stock. According to data from MarketBeat.com, Molina Healthcare currently has a consensus rating of “Hold” and a consensus price target of $196.33.

Molina Healthcare Profile

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.